Search

everythinglearnresearchcommunity

for

Search:↓

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

A higher testosterone to dihydrotestosterone ratio may indicate worse metabolic health in women.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

The study concluded that the most common skin problems in women with PCOS are excess hair, acne, oily skin, hair loss, dark skin patches, and skin tags.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

Apigenin and ellagic acid may help manage PCOS symptoms.

Men's facial appearance shows age, body fat, and testosterone levels, not metabolic health.